Literature DB >> 23616088

Alpha-synuclein and intracellular trafficking: impact on the spreading of Parkinson's disease pathology.

Sibylle E Eisbach1, Tiago F Outeiro.   

Abstract

Parkinson's disease is characterized by intracellular proteinaceous depositions known as Lewy bodies. These largely consist of the protein α-synuclein, whose physiological function remains unclear, but mutations and overexpression of the protein have been shown to cause early onset cases of Parkinson's disease. Deregulation of α-synuclein biology causes neurodegeneration and impaired neuronal trafficking, hinting at a possible contribution to the pathological mechanism. Recent studies produced some evidence hinting at the involvement of several regulators of the transport machinery such as Rab GTPases and SNARE proteins, but also shown that α-synuclein can be propagated between cells. Here, we discuss the molecular interplay of α-synuclein with the intracellular transport machinery, its consequences, and the implications for disease mechanisms.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23616088     DOI: 10.1007/s00109-013-1038-9

Source DB:  PubMed          Journal:  J Mol Med (Berl)        ISSN: 0946-2716            Impact factor:   4.599


  123 in total

Review 1.  Experimental support for the implication of oxidative stress in the genesis of parkinsonian syndromes.

Authors:  R G Fariello
Journal:  Funct Neurol       Date:  1988 Oct-Dec

2.  Oxidative stress induces amyloid-like aggregate formation of NACP/alpha-synuclein in vitro.

Authors:  M Hashimoto; L J Hsu; Y Xia; A Takeda; A Sisk; M Sundsmo; E Masliah
Journal:  Neuroreport       Date:  1999-03-17       Impact factor: 1.837

Review 3.  Rab proteins in regulated exocytosis.

Authors:  G Fischer von Mollard; B Stahl; C Li; T C Südhof; R Jahn
Journal:  Trends Biochem Sci       Date:  1994-04       Impact factor: 13.807

4.  Pathological changes in dopaminergic nerve cells of the substantia nigra and olfactory bulb in mice transgenic for truncated human alpha-synuclein(1-120): implications for Lewy body disorders.

Authors:  George K Tofaris; Pablo Garcia Reitböck; Trevor Humby; Sarah L Lambourne; Mark O'Connell; Bernardino Ghetti; Helen Gossage; Piers C Emson; Lawrence S Wilkinson; Michel Goedert; Maria Grazia Spillantini
Journal:  J Neurosci       Date:  2006-04-12       Impact factor: 6.167

5.  Alpha-synuclein implicated in Parkinson's disease is present in extracellular biological fluids, including human plasma.

Authors:  Omar M A El-Agnaf; Sultan A Salem; Katerina E Paleologou; Leanne J Cooper; Nigel J Fullwood; Mark J Gibson; Martin D Curran; Jennifer A Court; David M A Mann; Shu-ichi Ikeda; Mark R Cookson; John Hardy; David Allsop
Journal:  FASEB J       Date:  2003-08-15       Impact factor: 5.191

6.  Pars compacta of the substantia nigra modulates motor activity but is not involved importantly in regulating food and water intake.

Authors:  G K Hodge; L L Butcher
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1980-08       Impact factor: 3.000

7.  Alpha-synuclein promotes SNARE-complex assembly in vivo and in vitro.

Authors:  Jacqueline Burré; Manu Sharma; Theodoros Tsetsenis; Vladimir Buchman; Mark R Etherton; Thomas C Südhof
Journal:  Science       Date:  2010-08-26       Impact factor: 47.728

8.  α-Synuclein as CSF and Blood Biomarker of Dementia with Lewy Bodies.

Authors:  Kensaku Kasuga; Masatoyo Nishizawa; Takeshi Ikeuchi
Journal:  Int J Alzheimers Dis       Date:  2012-09-26

9.  α-Synuclein occurs physiologically as a helically folded tetramer that resists aggregation.

Authors:  Tim Bartels; Joanna G Choi; Dennis J Selkoe
Journal:  Nature       Date:  2011-08-14       Impact factor: 49.962

10.  Absence of alpha-synuclein affects dopamine metabolism and synaptic markers in the striatum of aging mice.

Authors:  Abdelmojib Al-Wandi; Natalia Ninkina; Steven Millership; Sally J M Williamson; Paul A Jones; Vladimir L Buchman
Journal:  Neurobiol Aging       Date:  2008-12-20       Impact factor: 4.673

View more
  27 in total

Review 1.  Dysregulation of Rab5-mediated endocytic pathways in Alzheimer's disease.

Authors:  Wei Xu; Fang Fang; Jianqing Ding; Chengbiao Wu
Journal:  Traffic       Date:  2018-02-05       Impact factor: 6.215

2.  The Gos28 SNARE protein mediates intra-Golgi transport of rhodopsin and is required for photoreceptor survival.

Authors:  Erica E Rosenbaum; Eva Vasiljevic; Spencer C Cleland; Carlos Flores; Nansi Jo Colley
Journal:  J Biol Chem       Date:  2014-09-26       Impact factor: 5.157

3.  Understanding neuronal dysfunction and loss in neurodegenerative disease.

Authors:  Flaviano Giorgini
Journal:  J Mol Med (Berl)       Date:  2013-06       Impact factor: 4.599

Review 4.  Dynamic droplets: the role of cytoplasmic inclusions in stress, function, and disease.

Authors:  Triana Amen; Daniel Kaganovich
Journal:  Cell Mol Life Sci       Date:  2014-10-05       Impact factor: 9.261

5.  Environmental and genetic factors support the dissociation between α-synuclein aggregation and toxicity.

Authors:  Anna Villar-Piqué; Tomás Lopes da Fonseca; Ricardo Sant'Anna; Éva Mónika Szegö; Luis Fonseca-Ornelas; Raquel Pinho; Anita Carija; Ellen Gerhardt; Caterina Masaracchia; Enrique Abad Gonzalez; Giulia Rossetti; Paolo Carloni; Claudio O Fernández; Debora Foguel; Ira Milosevic; Markus Zweckstetter; Salvador Ventura; Tiago Fleming Outeiro
Journal:  Proc Natl Acad Sci U S A       Date:  2016-10-05       Impact factor: 11.205

6.  Mutations in RAB39B cause X-linked intellectual disability and early-onset Parkinson disease with α-synuclein pathology.

Authors:  Gabrielle R Wilson; Joe C H Sim; Catriona McLean; Maila Giannandrea; Charles A Galea; Jessica R Riseley; Sarah E M Stephenson; Elizabeth Fitzpatrick; Stefan A Haas; Kate Pope; Kirk J Hogan; Ronald G Gregg; Catherine J Bromhead; David S Wargowski; Christopher H Lawrence; Paul A James; Andrew Churchyard; Yujing Gao; Dean G Phelan; Greta Gillies; Nicholas Salce; Lynn Stanford; Ashley P L Marsh; Maria L Mignogna; Susan J Hayflick; Richard J Leventer; Martin B Delatycki; George D Mellick; Vera M Kalscheuer; Patrizia D'Adamo; Melanie Bahlo; David J Amor; Paul J Lockhart
Journal:  Am J Hum Genet       Date:  2014-11-26       Impact factor: 11.025

7.  Reducing Endogenous α-Synuclein Mitigates the Degeneration of Selective Neuronal Populations in an Alzheimer's Disease Transgenic Mouse Model.

Authors:  Brian Spencer; Paula A Desplats; Cassia R Overk; Elvira Valera-Martin; Robert A Rissman; Chengbiao Wu; Michael Mante; Anthony Adame; Jazmin Florio; Edward Rockenstein; Eliezer Masliah
Journal:  J Neurosci       Date:  2016-07-27       Impact factor: 6.167

8.  Alpha-synuclein modulates retinal iron homeostasis by facilitating the uptake of transferrin-bound iron: Implications for visual manifestations of Parkinson's disease.

Authors:  Shounak Baksi; Ajai K Tripathi; Neena Singh
Journal:  Free Radic Biol Med       Date:  2016-06-23       Impact factor: 7.376

Review 9.  Pharmacological chaperoning of nAChRs: a therapeutic target for Parkinson's disease.

Authors:  Rahul Srinivasan; Brandon J Henderson; Henry A Lester; Christopher I Richards
Journal:  Pharmacol Res       Date:  2014-03-01       Impact factor: 7.658

10.  Synaptic phosphorylated α-synuclein in dementia with Lewy bodies.

Authors:  Martí Colom-Cadena; Jordi Pegueroles; Abigail G Herrmann; Christopher M Henstridge; Laia Muñoz; Marta Querol-Vilaseca; Carla San Martín-Paniello; Joan Luque-Cabecerans; Jordi Clarimon; Olivia Belbin; Raúl Núñez-Llaves; Rafael Blesa; Colin Smith; Chris-Anne McKenzie; Matthew P Frosch; Allyson Roe; Juan Fortea; Jordi Andilla; Pablo Loza-Alvarez; Ellen Gelpi; Bradley T Hyman; Tara L Spires-Jones; Alberto Lleó
Journal:  Brain       Date:  2017-12-01       Impact factor: 13.501

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.